↓ Skip to main content

Why We should Assess Patients’ Expectations in Clinical Trials

Overview of attention for article published in Pain and Therapy, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
40 X users

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
66 Mendeley
Title
Why We should Assess Patients’ Expectations in Clinical Trials
Published in
Pain and Therapy, May 2017
DOI 10.1007/s40122-017-0071-8
Pubmed ID
Authors

Elisa Frisaldi, Aziz Shaibani, Fabrizio Benedetti

Abstract

Most of the analgesic clinical trials have failed to succeed over the past years because of the occurrence of large placebo responses. Patients' expectations about the therapeutic benefit represent a major determinant of the placebo response. Therefore, assessing patients' expectations should become the rule in any clinical trial. This would allow us to better interpret therapeutic outcomes when comparing placebo and verum groups.

X Demographics

X Demographics

The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 65 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 17%
Researcher 10 15%
Student > Master 9 14%
Student > Ph. D. Student 8 12%
Other 6 9%
Other 9 14%
Unknown 13 20%
Readers by discipline Count As %
Medicine and Dentistry 18 27%
Nursing and Health Professions 11 17%
Psychology 9 14%
Neuroscience 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 3 5%
Unknown 19 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#1,674,870
of 25,353,525 outputs
Outputs from Pain and Therapy
#51
of 488 outputs
Outputs of similar age
#31,243
of 317,300 outputs
Outputs of similar age from Pain and Therapy
#3
of 7 outputs
Altmetric has tracked 25,353,525 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 488 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,300 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.